Showing 141-150 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Improving prediction of T1D risk by establishing a self-administered CGM-based technology and whole genome-based polygenic risk scores in diverse populations | Rector & Visitors of the University of Virginia | Leon Farhy | Cures | 01-August-2022 to 31-July-2025 | $599,999.66 |
| ST2 Tregs in enhancing islet transplantation | Rector & Visitors of the University of Virginia | Rahul Sharma | Cures | 01-July-2025 to 30-June-2028 | $499,997.13 |
| Alternative Splicing as a Trigger for Initiation and Progression of Islet Autoimmunity | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-February-2026 to 31-January-2029 | $880,914.00 |
| Evaluation of a novel insulin sensitizer on glycemic control, insulin usage, and cardiovascular biomarkers in people with type 1 diabetes who use closed-loop automated insulin delivery | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-August-2025 to 31-July-2028 | $1,031,908.99 |
| Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-December-2022 to 30-June-2027 | $858,072.00 |
| Advanced CGM analyses for longitudinal monitoring of early-stage Type 1 Diabetes | Regents of the University of Colorado | Andrea Steck | Cures | 01-October-2024 to 30-September-2027 | $900,000.00 |
| Clinic-based sleep screening and intervention to improve sleep health in adolescents with type 1 diabetes | Regents of the University of Colorado | Erin Cobry | Transportfolio | 01-April-2022 to 31-March-2027 | $750,000.00 |
| Cognitive behavioral therapy to address anxiety in pre symptomatic type 1 diabetes | Regents of the University of Colorado | Holly O’Donnell | Cures | 01-July-2024 to 30-June-2027 | $600,000.00 |
| EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM | Regents of the University of Colorado | Janet Snell-Bergeon | Improving Lives | 01-November-2022 to 31-October-2026 | $2,282,771.83 |
| Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | Regents of the University of Colorado | Jessica Kendrick | Improving Lives | 01-October-2022 to 30-September-2026 | $899,235.00 |